CellaVision
CellaVision acquires exclusive rights to novel microscopy technology
By AWA | Posted on April 8, 2021
AWA’s client CellaVision has signed an agreement to acquire the exclusive rights to a patent portfolio on Fourier Ptychographic Microscopy, a novel microscopy technology from Clearbridge BioPhotonics. CellaVision is an innovative, global medical technology company that develops and sells leading systems for routine analysis of blood and other body fluids in health care services. AWA...
Recent contributors
Senior Associate, Patents
Partner, European Patent Attorney, Authorised Swedish Patent Attorney, UPC Representative
Partner, Attorney at Law, Group Vice President
Senior Associate, Attorney at Law
Counsel, AU and NZ Patent Attorney
Senior Associate, China Patent Attorney